Literature DB >> 29147460

Corrigendum to "Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model".

Paola Songia1,2, Benedetta Porro1, Mattia Chiesa1, Veronika Myasoedova1, Francesco Alamanni1,3, Elena Tremoli1, Paolo Poggio1.   

Abstract

[This corrects the article DOI: 10.1155/2017/6838921.].

Entities:  

Year:  2017        PMID: 29147460      PMCID: PMC5632913          DOI: 10.1155/2017/3575348

Source DB:  PubMed          Journal:  Oxid Med Cell Longev        ISSN: 1942-0994            Impact factor:   6.543


In the article titled “Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model” [1], references [2, 3] should have been included as references 24 and 25 in the original article. Accordingly, in the introduction section, the text reading “Echocardiographically, MVP is defined as a single or bileaflet prolapse, at least 2 mm beyond the long-axis annular plane, while the assessment of valve regurgitation takes into account the effective regurgitant orifice area (EROA) [2]” should be changed to “Echocardiographically, MVP is defined as a single or bileaflet prolapse, at least 2 mm beyond the long-axis annular plane, while the assessment of the severity of MR relies on several parameters according to the current recommendations [24, 25].” Additionally, the Acknowledgments section should be updated as follows: “The authors thank the entire Cardiac Surgery Unit at Centro Cardiologico Monzino for the clinical data and blood collection. The authors also would like to thank Dr. Paola Gripari for patient evaluation and critical review. This work was supported by the Fondazione Gigi e Pupa Ferrari ONLUS and the Italian Ministry of Health [RC2015-BIO30-2613051 to Centro CardiologicoMonzino].”
  3 in total

Review 1.  Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance.

Authors:  William A Zoghbi; David Adams; Robert O Bonow; Maurice Enriquez-Sarano; Elyse Foster; Paul A Grayburn; Rebecca T Hahn; Yuchi Han; Judy Hung; Roberto M Lang; Stephen H Little; Dipan J Shah; Stanton Shernan; Paaladinesh Thavendiranathan; James D Thomas; Neil J Weissman
Journal:  J Am Soc Echocardiogr       Date:  2017-03-14       Impact factor: 5.251

2.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  Circulation       Date:  2014-03-03       Impact factor: 29.690

3.  Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model.

Authors:  Paola Songia; Benedetta Porro; Mattia Chiesa; Veronika Myasoedova; Francesco Alamanni; Elena Tremoli; Paolo Poggio
Journal:  Oxid Med Cell Longev       Date:  2017-02-02       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.